| 000 | 01761 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515223916.0 | ||
| 264 | 0 | _c20100701 | |
| 008 | 201007s 0 0 eng d | ||
| 022 | _a1532-6535 | ||
| 024 | 7 |
_a10.1038/clpt.2010.65 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPerkins, K A | |
| 245 | 0 | 0 |
_aCross-validation of a new procedure for early screening of smoking cessation medications in humans. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _cJul 2010 |
||
| 300 |
_a109-14 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Validation Study | ||
| 650 | 0 | 4 | _aAdministration, Cutaneous |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBenzazepines _xadverse effects |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aData Interpretation, Statistical |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMotivation |
| 650 | 0 | 4 |
_aNicotine _xadministration & dosage |
| 650 | 0 | 4 |
_aNicotinic Agonists _xadministration & dosage |
| 650 | 0 | 4 |
_aQuinoxalines _xadverse effects |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 |
_aSmoking _xpsychology |
| 650 | 0 | 4 |
_aSmoking Cessation _xmethods |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 | _aVarenicline |
| 700 | 1 | _aLerman, C | |
| 700 | 1 | _aFonte, C A | |
| 700 | 1 | _aMercincavage, M | |
| 700 | 1 | _aStitzer, M L | |
| 700 | 1 | _aChengappa, K N R | |
| 700 | 1 | _aJain, A | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 88 _gno. 1 _gp. 109-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/clpt.2010.65 _zAvailable from publisher's website |
| 999 |
_c19839055 _d19839055 |
||